{
    "root": "342c0d17-867e-d8da-e063-6394a90a3151",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Omeprazole and Sodium Bicarbonate",
    "value": "20250502",
    "ingredients": [
        {
            "name": "XYLITOL",
            "code": "VCQ006KQ1E"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE"
        },
        {
            "name": "OMEPRAZOLE",
            "code": "KG60484QX9"
        },
        {
            "name": "SODIUM BICARBONATE",
            "code": "8MDF5V39QO"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI"
        }
    ],
    "indications": "omeprazole sodium bicarbonate oral suspension omeprazole sodium bicarbonate capsules indicated adults : short-term treatment active duodenal ulcer . patients heal within four weeks . patients may require additional four weeks therapy . short-term treatment ( 4 8 weeks ) active benign gastric ulcer . treatment heartburn symptoms associated gerd 4 weeks . short-term treatment ( 4 8 weeks ) ee due acid-mediated gerd diagnosed endoscopy adults . efficacy omeprazole sodium bicarbonate used longer 8 weeks patients ee established . patient respond 8 weeks treatment , additional 4 weeks treatment may given . recurrence ee gerd symptoms ( e.g . , heartburn ) , additional 4 8-week courses omeprazole sodium bicarbonate may considered . maintenance healing ee due acid-mediated gerd . controlled extend beyond 12 months . omeprazole sodium bicarbonate oral suspension indicated adults : reduction risk upper gi bleeding critically ill adult patients .",
    "contraindications": "indication ( 2 ) recommended adult ( 2 ) omeprazole sodium bicarbonate oral suspension omeprazole sodium bicarbonate capsules ( 2 ) active duodenal ulcer ( 2 ) 20 mg daily 4 weeks ; patients may require additional 4 weeks ( 2 ) active benign gastric ulcer ( 2 ) 40 mg daily 4 8 weeks ( 2 ) treatment symptomatic gerd ( 2 ) 20 mg daily 4 weeks ( 2 ) treatment ee due acid-mediated gerd 20 mg daily 4 8 weeks * ( 2 ) maintenance healing ee due acid-mediated gerd ( 2 ) 20 mg daily * * ( 2 ) 40 mg omeprazole sodium bicarbonate oral suspension ( 2 ) reduction risk upper gi bleeding critically ill patients ( 2 ) 40 mg initially followed 40 mg 6 8 hours later 40 mg daily thereafter 14 days ( 2 ) * additional 4 weeks treatment may given response ; recurrence , additional 4 8-week courses may considered . ( 2 ) * * studied 12 months . ( 2 )",
    "warningsAndPrecautions": "omeprazole sodium bicarbonate supplied : omeprazole sodium bicarbonate capsules ndc strength quantity description 68682‑102‑30 20 mg omeprazole 1,100 mg sodium bicarbonate bottles 30 capsules opaque , hard gelatin , white capsule , imprinted santarus logo “ 20 ” 68682‑104‑30 40 mg omeprazole 1,100 mg sodium bicarbonate bottles 30 capsules opaque , hard gelatin , colored dark blue white capsule , imprinted santarus logo “ 40 ” omeprazole sodium bicarbonate oral suspension ndc strength quantity description 68682‑990‑30 20 mg omeprazole 1,680 mg sodium bicarbonate cartons 30 unit‑dose packets white , flavored powder packaged unit-dose packets 68682‑991‑30 40 mg omeprazole 1,680 mg sodium bicarbonate cartons 30 unit‑dose packets white , flavored powder packaged unit-dose packets . storage store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . keep container tightly closed . protect light moisture .",
    "adverseReactions": "omeprazole sodium bicarbonate contraindicated patients known hypersensitivity substituted benzimidazoles component formulation . hypersensitivity may include anaphylaxis , anaphylactic shock , angioedema , bronchospasm , acute tubulointerstitial nephritis , urticaria [ ( 5.2 ) error ! hyperlink reference valid . ( 6.2 ) ] . proton pump inhibitors ( ppis ) , including omeprazole sodium bicarbonate , contraindicated patients receiving rilpivirine containing products [ ( 7 ) ] .",
    "indications_original": "Omeprazole and Sodium Bicarbonate for oral suspension and Omeprazole and Sodium Bicarbonate capsules are indicated in adults for the:\n\n \n                  \n                     short-term treatment of active duodenal ulcer. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy.\n                     short-term treatment (4 to 8 weeks) of active benign gastric ulcer.\n                     treatment of heartburn and other symptoms associated with GERD for up to 4 weeks.\n                     short-term treatment (4 to 8 weeks) of EE due to acid-mediated GERD which has been diagnosed by endoscopy in adults.\n                     The efficacy of Omeprazole and Sodium Bicarbonate used for longer than 8 weeks in patients with EE has not been established. If a patient does not respond to 8 weeks of treatment, an additional 4 weeks of treatment may be given. If there is recurrence of EE or GERD symptoms (e.g., heartburn), additional 4 to 8-week courses of Omeprazole and Sodium Bicarbonate may be considered.\n                     maintenance of healing of EE due to acid-mediated GERD. Controlled studies do not extend beyond 12 months.\n                  \n                  \n                     Omeprazole and Sodium Bicarbonate for oral suspension is indicated in adults for the:\n\n \n                  \n                     reduction of risk of upper GI bleeding in critically ill adult patients.",
    "contraindications_original": "Indication ( 2 ) Recommended Adult Dosage ( 2 ) Omeprazole and Sodium Bicarbonate for oral suspension or Omeprazole and Sodium Bicarbonate capsules ( 2 ) Active Duodenal Ulcer ( 2 ) 20 mg once daily for 4 weeks; some patients may require an additional 4 weeks ( 2 ) Active Benign Gastric Ulcer ( 2 ) 40 mg once daily for 4 to 8 weeks ( 2 ) Treatment of Symptomatic GERD ( 2 ) 20 mg once daily for up to 4 weeks ( 2 ) Treatment of EE due to Acid-Mediated GERD 20 mg once daily for 4 to 8 weeks* ( 2 ) Maintenance of Healing of EE due to Acid-Mediated GERD ( 2 ) 20 mg once daily** ( 2 ) 40 mg Omeprazole and Sodium Bicarbonate for oral suspension ( 2 ) Reduction of Risk of Upper GI Bleeding in Critically Ill Patients ( 2 ) 40 mg initially followed by 40 mg 6 to 8 hours later and 40 mg once daily thereafter for 14 days ( 2 ) *an additional 4 weeks of treatment may be given if no response; if recurrence, additional 4 to 8-week courses may be considered. ( 2 ) **studied for 12 months. ( 2 )",
    "warningsAndPrecautions_original": "Omeprazole and Sodium Bicarbonate is supplied as:\n                  \n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 \n                                    Omeprazole and Sodium Bicarbonate Capsules\n                                 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 \n                                    NDC\n                                 \n                              \n                           \n                           \n                              \n                                 \n                                    Strength\n                                 \n                              \n                           \n                           \n                              \n                                 \n                                    Quantity\n                                 \n                              \n                           \n                           \n                              \n                                 \n                                    Description\n                                 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 68682‑102‑30\n                              \n                           \n                           \n                              \n                                 20 mg omeprazole and 1,100 mg sodium bicarbonate\n                              \n                           \n                           \n                              \n                                 Bottles of 30 capsules\n                              \n                           \n                           \n                              \n                                 Opaque, hard gelatin, white capsule, imprinted with the Santarus logo and “20”\n                              \n                           \n                        \n                        \n                           \n                              \n                                 68682‑104‑30\n                              \n                           \n                           \n                              \n                                 40 mg omeprazole and 1,100 mg sodium bicarbonate\n                              \n                           \n                           \n                              \n                                 Bottles of 30 capsules\n                              \n                           \n                           \n                              \n                                 Opaque, hard gelatin, colored dark blue and white capsule, imprinted with the Santarus logo and “40”\n                              \n                           \n                        \n                        \n                           \n                              \n                                 \n                                    Omeprazole and Sodium Bicarbonate for Oral Suspension\n                                 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 \n                                    NDC\n                                 \n                              \n                           \n                           \n                              \n                                 \n                                    Strength\n                                 \n                              \n                           \n                           \n                              \n                                 \n                                    Quantity\n                                 \n                              \n                           \n                           \n                              \n                                 \n                                    Description\n                                 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 68682‑990‑30\n                              \n                           \n                           \n                              \n                                 20 mg omeprazole and 1,680 mg sodium bicarbonate\n                              \n                           \n                           \n                              \n                                 Cartons of 30 unit‑dose packets\n                              \n                           \n                           \n                              \n                                 White, flavored powder packaged in unit-dose packets\n                              \n                           \n                        \n                        \n                           \n                              \n                                 68682‑991‑30\n                              \n                           \n                           \n                              \n                                 40 mg omeprazole and 1,680 mg sodium bicarbonate\n                              \n                           \n                           \n                              \n                                 Cartons of 30 unit‑dose packets\n                              \n                           \n                           \n                              \n                                 White, flavored powder packaged in unit-dose packets.\n                              \n                           \n                        \n                     \n                  \n                  \n                     Storage\n                  \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n                  Keep container tightly closed. Protect from light and moisture.",
    "adverseReactions_original": "Omeprazole and Sodium Bicarbonate is contraindicated in patients with known hypersensitivity to substituted benzimidazoles or to any component of the formulation. Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria\n \n  [see\n  \n   Warnings and Precautions (5.2)\n                     \n                     Error! Hyperlink reference not valid.\n                     Adverse Reactions (6.2)].\n\n \n                  Proton pump inhibitors (PPIs), including Omeprazole and Sodium Bicarbonate, are contraindicated in patients receiving rilpivirine containing products\n \n  [see\n  \n   Drug Interactions (7)]\n \n  ."
}